Gene · 1859
Papers3,825
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,825
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Design, synthesis, and structure-activity relationship studies of 6H-benzo[b]indeno[1,2-d]thiophen-6-one derivatives as DYRK1A/CLK1/CLK4/haspin inhibitors. | RSC Med Chem | 2025 | 39430953 | PubTator, text mining | PubMed |
| Visual and auditory attention in individuals with DYRK1A and SCN2A disruptive variants. | Autism Res | 2025 | 39080977 | PubTator, text mining | PubMed |
| Discovery of a novel DYRK1A inhibitor with neuroprotective activity by virtual screening and in vitro biological evaluation. | Mol Divers | 2025 | 38833123 | PubTator, text mining | PubMed |
| Naturally occurring caffeic acid phenethyl ester from chestnut honey-based propolis and virtual screening towards DYRK1A. | Nat Prod Res | 2025 | 38300844 | PubTator, text mining | PubMed |
| Ribosomal Proteins in Ribosome Assembly. | Biomolecules | 2024 | 39858408 | PubTator, text mining | PubMed |
| THE FAM53C/DYRK1A axis regulates the G1/S transition of the cell cycle. | bioRxiv | 2024 | 39713326 | PubTator, text mining | PubMed |
| [Research progress on the cognitive deficit of Down syndrome patients]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2024 | 39653359 | PubTator, text mining | PubMed |
| DYRK2 controls GSTPI expression through ubiquitination and degradation of Twist1 to reduce chemotherapy resistance caused by EMT in breast cancer. | J Mol Histol | 2024 | 39641870 | PubTator, text mining | PubMed |
| Cycling alpha cells in regenerative drug-treated human pancreatic islets may serve as key beta cell progenitors. | Cell Rep Med | 2024 | 39626675 | PubTator, text mining | PubMed |
| Analysis of 1386 epileptogenic brain lesions reveals association with DYRK1A and EGFR. | Nat Commun | 2024 | 39616148 | PubTator, text mining | PubMed |
| Corrigendum: Functional rejuvenation of aged neural stem cells by Plagl2 and anti-Dyrk1a activity. | Genes Dev | 2024 | 39603716 | PubTator, text mining | PubMed |
| Novel Thiazole-Fused [4,5-g] or [5,4-g]Quinazolin-8-ones and Their Quinazoline Analogues: Synthesis and Biological Evaluation. | Pharmaceuticals (Basel) | 2024 | 39598364 | PubTator, text mining | PubMed |
| Discovery of dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) inhibitors using an artificial intelligence model and their effects on tau and tubulin dynamics. | Biomed Pharmacother | 2024 | 39591664 | PubTator, text mining | PubMed |
| SPACe: an open-source, single-cell analysis of Cell Painting data. | Nat Commun | 2024 | 39580445 | PubTator, text mining | PubMed |
| Plasma p-tau212 as a biomarker of sporadic and Down Syndrome Alzheimer's disease. | medRxiv | 2024 | 39574868 | PubTator, text mining | PubMed |
| Unveiling the antiglioblastoma potential of harmicens, harmine and ferrocene hybrids. | Acta Pharm | 2024 | 39560310 | PubTator, text mining | PubMed |
| Targeted protein degradation: advances in drug discovery and clinical practice. | Signal Transduct Target Ther | 2024 | 39500878 | PubTator, text mining | PubMed |
| Discovering a novel dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) inhibitor and its impact on tau phosphorylation and amyloid-β formation. | J Enzyme Inhib Med Chem | 2024 | 39494990 | PubTator, text mining | PubMed |
| Molecular pathways and biological roles of melatonin and vitamin D; effects on immune system and oxidative stress. | Int Immunopharmacol | 2024 | 39488920 | PubTator, text mining | PubMed |
| DYRK1A interacts with the tuberous sclerosis complex and promotes mTORC1 activity. | Elife | 2024 | 39436397 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1859/papers?page=10